Results 181 to 190 of about 118,357 (315)

LL‐37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Human cathelicidin peptide LL‐37 is encoded by the CAMP gene and plays a key role in innate immunity. It maintains intestinal homeostasis through antibacterial, immunomodulation, and tissue repair functions. This paper reviews the multiple functions of LL‐37 in the intestinal‐immune axis and its contribution to intestinal immune homeostasis. A
Qichao Liu, Peng Xu, Cheng Zhang
wiley   +1 more source

Clinical Profile of Kawasaki Disease (KD) in Children admitted at Dhaka Shishu Hospital

open access: diamond, 2017
Mamun Miah   +5 more
openalex   +2 more sources

Leadership and Research Productivity in Japan's Academic Departments of Regional Healthcare: A Nationwide Cross‐Sectional Study

open access: yesJournal of General and Family Medicine, Volume 27, Issue 3, May 2026.
ABSTRACT Background Academic departments related to regional health care in Japan play a crucial role in addressing healthcare disparities and workforce shortages. However, a comprehensive understanding of their structures, leadership, and activities is lacking. This study aimed to provide the first nationwide profile of academic departments related to
Hiroki Yasuhara   +5 more
wiley   +1 more source

Kawasaki Disease and the Importance of Family History. [PDF]

open access: yesJACC Case Rep
Maadanian DH, Shimizu C, Burns JC.
europepmc   +1 more source

Additional file 2 of Phillyrin alleviates Kawasaki disease-induced lung inflammation by inhibiting platelet production through the NLRP3/IL-1β/NF-E2 signaling pathway

open access: green
Da-Hao Mai   +10 more
openalex   +1 more source

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita   +116 more
wiley   +1 more source

Home - About - Disclaimer - Privacy